GeneXpert MTB/RIF Ultra在肺外结核诊断中的研究进展

doi:10.19982/j.issn.1000-6621.20230357

摘要/Abstract

摘要：

肺外结核是结核病的一种类型,其感染途径和感染部位多样,临床表现复杂,缺乏特异性诊断。目前,病原学和免疫学诊断方法存在弊端,临床亟需能够快速准确诊断肺外结核的实验室方法,以满足早期诊断的需求,配合临床及时开展治疗。GeneXpert MTB/RIF Ultra(简称“Xpert Ultra”)作为一种新型的分子诊断工具,为肺外结核的快速精准诊断开启了新篇章。笔者对Xpert Ultra在各类肺外结核不同标本类型中的诊断效能进行综述,旨在评价其应用价值,为肺外结核诊断提供新思路。

关键词: 分子诊断技术, 结核, 诊断

Abstract:

Extrapulmonary tuberculosis is a form of tuberculosis characterized by various infection routes and sites, complex clinical manifestations, and a lack of specific diagnosis. Currently, there are limitations in etiological and immunological diagnostic methods, and there is an urgent need for laboratory techniques that can quickly and accurately diagnose extrapulmonary tuberculosis to facilitate early detection and timely treatment. GeneXpert MTB/RIF Ultra (Xpert Ultra) is a novel molecular diagnostic tool that has revolutionized the rapid and precise diagnosis of extrapulmonary tuberculosis. The author examines the diagnostic effectiveness of Xpert Ultra in different types of extrapulmonary tuberculosis specimens, aiming to assess its clinical value and offer new insights into the diagnosis of extrapulmonary tuberculosis.

Key words: Molecular diagnostic techniques, Tuberculosis, Diagnosis

中图分类号:

R52
R378.91

董裕, 张福真, 尚媛媛, 逄宇. GeneXpert MTB/RIF Ultra在肺外结核诊断中的研究进展[J]. 中国防痨杂志, 2023, 45(12): 1193-1197. doi: 10.19982/j.issn.1000-6621.20230357

Dong Yu, Zhang Fuzhen, Shang Yuanyuan, Pang Yu. Progress of diagnosis of extrapulmonary tuberculosis with GeneXpert MTB/RIF Ultra[J]. Chinese Journal of Antituberculosis, 2023, 45(12): 1193-1197. doi: 10.19982/j.issn.1000-6621.20230357

参考文献 36

[1]	Mehta PK, Raj A, Singh N, et al. Diagnosis of extrapulmonary tuberculosis by PCR. FEMS Immunol Med Microbiol, 2012, 66(1):20-36. doi:10.1111/j.1574-695X.2012.00987.x.
[2]	Pang Y, An J, Shu W, et al. Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008—2017. Emerg Infect Dis, 2019, 25(3):457-464. doi:10.3201/eid2503.180572. pmid: 30789144
[3]	Acharya B, Acharya A, Gautam S, et al. Advances in diagnosis of Tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis. Mol Biol Rep, 2020, 47(5):4065-4075. doi:10.1007/s11033-020-05413-7.
[4]	陆迪雅, 陈澍. T淋巴细胞酶联免疫斑点法在肺外结核诊断中的应用. 中华传染病杂志, 2013, 31(6):377-385. doi:10.3760/cma.j.issn.1000-6680.2013.06.016.
[5]	逄宇, 高兴辉, 汤一苇, 等. 基于结核病宿主免疫反应的实验室检测技术及其临床应用. 中国防痨杂志, 2021, 43(9):883-892. doi:10.3969/j.issn.1000-6621.2021.09.006.
[6]	Goletti D, Delogu G, Matteelli A, et al. The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection. Int J Infect Dis, 2022, 124 Suppl 1:S12-S19. doi:10.1016/j.ijid.2022.02.047.
[7]	Shapiro AE, Ross JM, Yao M, et al. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms. Cochrane Database Syst Rev, 2021, 3(3):CD013694. doi:10.1002/14651858.CD013694.pub2.
[8]	Rindi L. Rapid Molecular Diagnosis of Extra-Pulmonary Tuberculosis by Xpert/RIF Ultra. Front Microbiol, 2022, 13:817661. doi:10.3389/fmicb.2022.817661.
[9]	Kolia-Diafouka P, Carrère-Kremer S, Lounnas M, et al. Detection of Mycobacterium tuberculosis in paucibacillary sputum: performances of the Xpert MTB/RIF ultra compared to the Xpert MTB/RIF, and IS6110 PCR. Diagn Microbiol Infect Dis, 2019, 94(4):365-370. doi:10.1016/j.diagmicrobio.2019.02.008.
[10]	Park M, Kon OM. Use of Xpert MTB/RIF and Xpert Ultra in extrapulmonary tuberculosis. Expert Rev Anti Infect Ther, 2021, 19(1):65-77. doi:10.1080/14787210.2020.1810565.
[11]	王淑琦, 黄海荣, 王桂荣. Xpert MTB/RIF Ultra与Xpert MTB/RIF检测技术的临床应用及研究进展. 中国防痨杂志, 2018, 40(7):776-780. doi:10.3969/j.issn.1000-6621.2018.07.020.
[12]	Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis, 2018, 18(1):76-84. doi:10.1016/S1473-3099(17)30691-6. pmid: 29198911
[13]	玄琦月, 韩雪, 付英梅. 肺外结核病微生物学诊断方法的研究和应用进展. 生物技术进展, 2021, 11(1):47-53. doi:10.19586/j.2095-2341.2020.0079.
[14]	Thao LTP, Heemskerk AD, Geskus RB, et al. Prognostic Models for 9-Month Mortality in Tuberculous Meningitis. Clin Infect Dis, 2018, 66(4):523-532. doi:10.1093/cid/cix849. pmid: 29029055
[15]	Poplin V, Boulware DR, Bahr NC. Methods for rapid diagnosis of meningitis etiology in adults. Biomark Med, 2020, 14(6):459-479. doi:10.2217/bmm-2019-0333. pmid: 32270693
[16]	Jullien S, Ryan H, Modi M, et al. Six months therapy for tuberculous meningitis. Cochrane Database Syst Rev, 2016, 9(9):CD012091. doi:10.1002/14651858.CD012091.pub2.
[17]	Donovan J, Thu DDA, Phu NH, et al. Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study. Lancet Infect Dis, 2020, 20(3):299-307. doi:10.1016/S1473-3099(19)30649-8. pmid: 31924551
[18]	Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis, 2010, 10(11):803-812. doi:10.1016/S1473-3099(10)70138-9. pmid: 20822958
[19]	Cresswell FV, Tugume L, Bahr NC, et al. Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study. Lancet Infect Dis, 2020, 20(3):308-317. doi:10.1016/S1473-3099(19)30550-X. pmid: 31924549
[20]	Bahr NC, Nuwagira E, Evans EE, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis, 2018, 18(1):68-75. doi:10.1016/S1473-3099(17)30474-7. pmid: 28919338
[21]	Shen Y, Yu G, Zhao W, et al. Efficacy of Xpert MTB/RIF Ultra in diagnosing tuberculosis meningitis: A systematic review and meta-analysis. Medicine (Baltimore), 2021, 100(29):e26778. doi:10.1097/MD.0000000000026778.
[22]	Norbis L, Alagna R, Tortoli E, et al. Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis. Expert Rev Anti Infect Ther, 2014, 12(5):633-647. doi:10.1586/14787210.2014.899900. pmid: 24717112
[23]	Chen X, Ye J, Lei H, et al. Novel Potential Diagnostic Serum Biomarkers of Metabolomics in Osteoarticular Tuberculosis Patients: A Preliminary Study. Front Cell Infect Microbiol, 2022, 12:827528. doi:10.3389/fcimb.2022.827528.
[24]	Mohanty M, Mishra B, Jain M, et al. Diagnostic role of Xpert-MTB RIF assay in osteoarticular tuberculosis: A retrospective study. World J Orthop, 2022, 13(3):289-296. doi:10.5312/wjo.v13.i3.289. pmid: 35317258
[25]	Yi L, Li Z, Jiang H, et al. Gene Modification of Transforming Growth Factor β (TGF-β) and Interleukin 10 (IL-10) in Suppressing Mt Sonicate Induced Osteoclast Formation and Bone Absorption. Med Sci Monit, 2018, 24:5200-5207. doi:10.12659/MSM.909720.
[26]	Ngcelwane M, Omar SV, Said M, et al. New Horizons in the Diagnosis of Tuberculosis of the Spine: The Role of Whole Genome Sequencing. Asian Spine J, 2023, 17(3):511-517. doi:10.31616/asj.2022.0247. pmid: 37194130
[27]	Sun Q, Wang S, Dong W, et al. Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis. J Infect, 2019, 79(2):153-158. doi:10.1016/j.jinf.2019.06.006. pmid: 31207324
[28]	Mekkaoui L, Hallin M, Mouchet F, et al. Performance of Xpert MTB/RIF Ultra for diagnosis of pulmonary and extra-pulmonary tuberculosis, one year of use in a multi-centric hospital laboratory in Brussels, Belgium. PLoS One, 2021, 16(4):e0249734. doi:10.1371/journal.pone.0249734.
[29]	Basri Z, Rita AB, Lakhdari A, et al. Lymph node tuberculosis mimicking axillary hidradenitis: a case report. Pan Afr Med J, 2022, 43:98. doi:10.11604/pamj.2022.43.98.33903. pmid: 36660084
[30]	Yu G, Zhong F, Ye B, et al. Diagnostic Accuracy of the Xpert MTB/RIF Assay for Lymph Node Tuberculosis: A Systematic Review and Meta-Analysis. Biomed Res Int, 2019, 2019:4878240. doi:10.1155/2019/4878240.
[31]	Perez-Risco D, Rodriguez-Temporal D, Valledor-Sanchez I, et al. Evaluation of the Xpert MTB/RIF Ultra Assay for Direct Detection of Mycobacterium tuberculosis Complex in Smear-Negative Extrapulmonary Samples. J Clin Microbiol, 2018, 56(9):e00659-18. doi:10.1128/JCM.00659-18.
[32]	Antel K, Oosthuizen J, Malherbe F, et al. Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis. BMC Infect Dis, 2020, 20(1):33. doi:10.1186/s12879-019-4749-x. pmid: 31931736
[33]	Figueiredo AA, Lucon AM, Gomes CM, et al. Urogenital tuberculosis: patient classification in seven different groups according to clinical and radiological presentation. Int Braz J Urol, 2008, 34(4):422-432. doi:10.1590/s1677-55382008000400004. pmid: 18778493
[34]	Muneer A, Macrae B, Krishnamoorthy S, et al. Urogenital tuberculosis-epidemiology, pathogenesis and clinical features. Nat Rev Urol, 2019, 16(10):573-598. doi:10.1038/s41585-019-0228-9. pmid: 31548730
[35]	López-Roa P, Martin-Higuera C, Ruiz-Serrano MJ, et al. Performance of Xpert MTB/RIF Ultra assay on respiratory and extra-respiratory samples in a high-resource setting with a low tuberculosis prevalence. Diagn Microbiol Infect Dis, 2021, 99(2):115235. doi:10.1016/j.diagmicrobio.2020.115235.
[36]	Opota O, Mazza-Stalder J, Greub G, et al. The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection. Clin Microbiol Infect, 2019, 25(11):1370-1376. doi:10.1016/j.cmi.2019.03.021.